Prediction of Tubulin Inhibitor Sensitivity in Colon Cancer
José Liñares-Blanco, Irene Chicote, Javier Ros, Anna M. Alcántara, Jordi Martínez‐Quintanilla, Elena Élez, Héctor G. Pálmer, Carlos Fernandez-Lozano, José Antonio Seoane
This study develops a 37-gene prognostic signature for colon cancer and identifies a subgroup sensitive to tubulin inhibitors, with potential for drug repurposing.
bioRxiv · Jan 14, 2025 · PreprintCancer Biology